Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2018 Photo Hanno Otto
Odeion School of Music opening concert presented on 17 March 2018
The Odeion School of Music Camerata 2018.

The University of the Free State’s Odeion School of Music is presenting the annual opening concert on Saturday, 17 March at 7:30pm at the Odeion. The programme will comprise a curated sequence of solo recitals, chamber music, including ensembles recited by the talented OSM students.

The Free State Youth Wind Ensemble will make their debut as part of the programme with an Ammerland recital by the Dutch composer Jacob den Haan (1959 -) as well as Majestia by James Swearingen (1947 -), an American born composer. This composition will be accompanied by a variety of diverse works.

George Foster and colleague Danré Strydom founded the ensemble in the form of a collaboration initiative between the Odeion School of Music and the Free State Symphony Orchestra. Six cellists, Chris van Zyl, Aschlin Grobbelaar, Marcus Motaung, Matthys Coetzee and John Minnaar will join forces with Prof Anmari van der Westhuizen to recite the riveting Requiem for Six Cellos and Piano, Op.66 by David Popper. 

During the concert, the OSM will bestow the Order of the OSM on string pedagogues Francois and Tilla Henkins, as a gesture of gratitude and respect for their lifelong dedication to the education and mentoring of several excellent South African violinists and cellists.

The OSM Camerata will end the concert with a rendition of the Romanian Folk Dances, Sz.56 Béla Bartok for Orchestra under the baton of Xavier Cloete. The OSM Camerata is the laureate of the first International Ictus Music Competition (University and Conservatory Orchestras) presented last year for the first time. For more information about the Odeion School of Music and the upcoming concert please visit the website.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept